Yujie Su, MS

Illumination Health, Hoover, AL, USA

Poster(s):

• (021) Line of Therapy of Biologics and JAK Inhibitors in RA, PsA, and AxSpA: Implications for Design and Uptake of New Drugs and Diagnostics
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (041) Use of Digital Health Tools to Evaluate Change in Clinical and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis Initiating Treatment with a JAKi or TNFi
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (042) Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (187) Will Patients engage with Digiatl Technologies as part of Routine Healthcare?
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (ASPOT13) Patient Engagement and Adherence to Digital Tasks: WEARable Activity Tracker Study Exploring Rheumatoid Arthritis Patients’ Disease Activity using Patient-Reported Outcome Measures, Clinical Measures, and Biometric Sensor Data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST